Page last updated: 2024-08-17

reserpine and 4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide

reserpine has been researched along with 4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J1
Cross, AJ; Howell, A; Hudzik, TJ; Payza, K1
Brotchie, JM; Crossman, AR; Fox, SH; Hille, CJ; Maneuf, YP1

Other Studies

4 other study(ies) available for reserpine and 4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
    Nature chemical biology, 2009, Volume: 5, Issue:10

    Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection

2009
Antiparkinson potential of delta-opioid receptor agonists.
    European journal of pharmacology, 2000, May-19, Volume: 396, Issue:2-3

    Topics: Animals; Antiparkinson Agents; Azocines; Benzamides; Male; Motor Activity; Piperazines; Rats; Rats, Long-Evans; Receptors, Opioid, delta; Reserpine; Rotation

2000
Antiparkinsonian action of a delta opioid agonist in rodent and primate models of Parkinson's disease.
    Experimental neurology, 2001, Volume: 172, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adrenergic Uptake Inhibitors; Animals; Behavior, Animal; Benzamides; Callithrix; Dopamine Antagonists; Dose-Response Relationship, Drug; Female; Male; Motor Activity; Narcotic Antagonists; Parkinsonian Disorders; Piperazines; Posture; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Reserpine

2001